Showing results (231-240 of 481) with videos related to

Sort By:
Pageof 49
Science Translational Medicine|May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemiaDavid Wu, Anna Sherwood, Jonathan R Fromm, et al.
Human Heredity|August 7, 2014
A new system identification approach to identify genetic variants in sequencing studies for a binary phenotypeGuolian Kang, Wenjian Bi, Yanlong Zhao, et al.
The Medical Journal of Malaysia|February 3, 2020
The objective assessment of the effects on cognition functioning among military personnel exposed to hypobaric-hypoxia: A pilot fMRI studyS N Nisha, A S Fathinul Fikri, A R Aida, et al.
JCO Clinical Cancer Informatics|May 2, 2025
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL SubtypesWenan Chen, Ti-Cheng Chang, Karen R Rabin, et al.
Pediatric Blood & Cancer|May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Leukemia|September 24, 2004
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer GroupM L Loh, M G Reynolds, S Vattikuti, et al.
Leukemia|September 27, 2008
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group studyK Nguyen, M Devidas, S-C Cheng, et al.
Leukemia|June 10, 2018
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cellsSarah K Tasian, Jessica A Casas, David Posocco, et al.
Haematologica|June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trialLaura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Pageof 49